Skip to main content

Table 5 Associated analysis of PE and adverse pregnancy outcomes

From: A study of adverse maternal-foetal outcomes in nephrotic syndrome combined with preeclampsia

Pregnancy outcomes

NS + PE(30)

NS (60)

OR(95%CI)

P

premature birth

 Model A1:

8.25

1

3.04–22.38

< 0.001

 Model A2:

8.25

1

2.73–24.95

< 0.001

 Model A3:

7.26

1

2.54–20.70

< 0.001

Foetal birth restriction

 Model B1:

7.43

1

2.64–20.89

< 0.001

 Model B2:

5.71

1

1.95–16.71

0.001

 Model B3:

4.07

1

1.32–12.51

0.014

foetal distress

 Model C1:

5.67

1

2.07–15.51

0.001

 Model C2:

4.26

1

1.49–12.19

0.007

 Model C3:

2.69

1

0.87–8.35

0.085

Low birth weight babies

 Model D1:

6.00

1

2.30–15.64

< 0.001

 Model D2:

4.77

1

1.77–12.87

0.002

 Model D3:

3.42

1

1.21–9.69

0.021

abortion

 Model E1:

2.20

1

0.58–8.29

0.24

 Model E2:

4.87

1

1.05–22.71

0.044

 Model E3:

4.79

1

0.97–23.65

0.55

maternal outcome

 postpartum haemorrhage

  Model F1:

1.50

1

0.58–3.91

0.41

  Model F2:

1.58

1

0.51–4.29

0.43

  Model F3:

1.94

1

0.55–6.85

0.30

Haemorrhagic salpingitis

 Model G1:

4.21

1

0.37–48.46

0.25

 Model G2:

4.82

1

0.25–93.35

0.30

 Model G3:

6.57

1

0.08–549

0.41

  1. Model 1: Unadjusted
  2. Model 2: Adjusted for 24-H urine protein, number of pregnancies, and history of cesarean delivery
  3. Model 3: Further adjusted for total calcium level, uric acid, serum triglycerides, and RBC based on model 2